# Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

> **NCT02782754** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Intracranial Germinoma

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Etoposide
- **DRUG:** Cyclophosphamide
- **DRUG:** Bleomycin
- **RADIATION:** Reduced dose of radiotherapy

## Key facts

- **NCT ID:** NCT02782754
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02782754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02782754, "Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT02782754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*